A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma

By Gortzak E.   Azzarelli A.   Buesa J.   Bramwell V.H.C.   van Coevorden F.   van Geel A.N.   Ezzat  

European Journal of Cancer, Vol. 37, Iss. 9, 2001-06 ,pp. : 1096-1103

Elsevier

Access to resources Recommend Favorite

Chemotherapy of Soft Tissue Sarcoma

By Wall Najme   Wall Najme  

Acta Oncologica, Vol. 42, Iss. 1, 2003-01 ,pp. : 55-61

Informa Healthcare

Access to resources Recommend Favorite

Lack of ErbB-2 Oncogene Product Overexpression in Soft Tissue Sarcomas

By Merimsky Ofer   Issakov Josephine   Schwartz Ignat   Dadia Shlomo   Kollender Yehuda   Bickels Jacob   Inbar Moshe   Meller Isaac  

Acta Oncologica, Vol. 41, Iss. 4, 2002-06 ,pp. : 366-368

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults - long-term results of a phase II study

By Issels R.D.   Abdel-Rahman S.   Wendtner C.-M.   Falk M.H.   Kurze V.   Sauer H.   Aydemir U.   Hiddemann W.  

European Journal of Cancer, Vol. 37, Iss. 13, 2001-09 ,pp. : 1599-1608

Elsevier

Access to resources Recommend Favorite

Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults - results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia

By Wendtner C.-M.   Abdel-Rahman S.   Baumert J.   Falk M.H.   Krych M.   Santl M.   Hiddemann W.   Issels R.D.  

European Journal of Cancer, Vol. 37, Iss. 13, 2001-09 ,pp. : 1609-1616

Elsevier

Access to resources Recommend Favorite